← Leaderboards
Masoud H Manjili
Virginia Commonwealth University
$915,485
Attributed
$915,485
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $235.4K · FY2005–09$250K$187.5K$125K$62.5K$0
'05
'06
'07
'08
'09
Funding mix
By agency
NIH$915,485 · 2
By mechanism
R01$911,752 · 1
M01$3,733 · 1
Top collaborators
No co-investigators on record.
Most similar at Virginia Commonwealth University
Same institution · by research overlap
- Qingsheng Li$6,335,723
- Mitzi Nagarkatti$16,087,844
- Christopher M Sheth$57,729
- John G Tew$2,988,143
- Stuart P Adler$6,019,096
Others in their field
Top investigators on “T-Lymphocyte”
- Barton F Haynes · Duke University$296,833,570
- Lawrence Corey · Fred Hutchinson Cancer Center$270,341,865
- Dan H. Barouch · Fred Hutchinson Cancer Center$117,305,894
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$107,651,960
- Alessandro Sette · La Jolla Institute For Immunology$75,756,097
- Rama Rao Amara · Emory University$69,530,112
Research focus
T-LymphocyteImmunityNeoplastic CellTumorBinding (Molecular Function)BaseLeadMouse ModelProteinsAntigensErbb2 GeneExtracellular DomainAntibodiesMalignant NeoplasmsImmune ResponseCancer PatientFormulations, DrugComplexFailure (Biologic Function)FutureCollaborationsClinical TrialsBiological ModelsClinical Application
Grant awards (5)
DETERMINATION OF DISTINCT TYPES OF IMMUNE RESPONSES TO HER-2/NEU ASSOCIATED W$3,733
M01 · FY2009 · RR · contact PI
Enhancement of HER-2/neu-based therapy using HSP110$223,222
R01 · FY2008 · CA · contact PI
Enhancement of HER-2/neu-based therapy using HSP110$223,222
R01 · FY2007 · CA · contact PI
Enhancement of HER-2/neu-based therapy using HSP110$229,888
R01 · FY2006 · CA · contact PI
Enhancement of HER-2/neu-based therapy using HSP110$235,420
R01 · FY2005 · CA